Mounjaro weight loss tablets: separating fact from a common mix-up

The tablet confusion that comes up constantly

It is one of the most common questions our prescribers encounter: can you get Mounjaro in tablet form? The short answer is no, and it is worth understanding why, because the confusion is understandable rather than careless. Several weight-loss medicines are tablets (weight loss tablets similar in purpose to Mounjaro do exist) and people reasonably assume a newer, highly publicised medicine might come in a more familiar format.

Tirzepatide, the active ingredient in Mounjaro, has only been approved in an injectable form in the UK. Eli Lilly, who manufactures it, markets it as a subcutaneous injection delivered via a pre-filled KwikPen, with each pen containing four weekly doses. There is no licensed oral tirzepatide for weight management available here. If you have read about Mounjaro tablets, those references are either to overseas markets, unapproved versions, or a separate medicine altogether, and that distinction matters both clinically and legally.

The only oral GLP-1 medicine approved in the UK for weight management as of summer 2026 is Wegovy tablets (oral semaglutide), which received MHRA approval on 11 June 2026. It contains a different active ingredient and follows a different dosing schedule. You can read more about tirzepatide more broadly at our tirzepatide overview.

How tirzepatide actually produces weight loss

Understanding the mechanism helps make sense of why this medicine requires injection. Tirzepatide is a dual GIP and GLP-1 receptor agonist, it activates two gut-hormone pathways simultaneously. GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) are both released after eating, and together they reduce appetite, slow the rate at which food leaves the stomach, and influence how the brain registers fullness. No other weight-loss medicine currently licensed in the UK targets both pathways, which is why tirzepatide sits in a category of its own.

Because tirzepatide is a large peptide molecule, stomach acid would break it down before it could be absorbed if taken orally in its current formulation. The subcutaneous injection bypasses that process entirely, delivering the molecule directly into the tissue beneath the skin. The injection itself uses a very fine needle and is administered once a week, typically into the abdomen, thigh, or upper arm, rotating sites each time.

The NHS has published detailed patient-level information about how tirzepatide works and what to expect, which is worth reading alongside any consultation. Dosing starts at 2.5 mg (a level designed to let your body adjust) and is titrated by your prescriber over time. What you take and when is a clinical decision, not something to adjust independently.

What the trial evidence shows for tirzepatide tablets for weight loss searches

People searching for tirzepatide tablets for weight loss are often driven by the same thing: the clinical results are striking, and they want to know whether they are real. They are. The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed 2,539 adults with obesity over 72 weeks. At the 15 mg dose, participants lost an average of around 20–21% of body weight alongside a reduced-calorie diet and increased physical activity. Those are figures that had not been seen with any previous non-surgical weight-management medicine in the UK.

NICE reviewed this evidence carefully and recommended tirzepatide for NHS use in adults with a BMI of 35 or above plus at least one weight-related health condition, though private eligibility, per the licensed criteria, begins at a BMI of 30, or 27 with a relevant condition such as high blood pressure, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. The NICE appraisal is published at TA1026 on the NICE website.

One practical note on cost: Eli Lilly raised Mounjaro's UK list price from September 2025, with private prices now typically ranging roughly £149–£375 per month depending on dose and provider. For a fuller breakdown of what drives those figures, our Mounjaro weight loss page covers the cost context in detail. The price of a prescription medicine is only part of the picture; what matters equally is the clinical oversight behind it.

Who Mounjaro is licensed for, and what comes next

Mounjaro holds a UK licence for weight management in adults, used alongside a reduced-calorie diet and increased physical activity. The licensed eligibility threshold is a BMI of 30 or above, or 27 or above where at least one weight-related condition is present. BMI alone does not guarantee clinical approval; your prescriber will consider your full health history, current medicines, and any contraindications before making a decision.

Mounjaro is not recommended during pregnancy, while breastfeeding, or for those actively trying to conceive. It is not licensed for anyone under 18. People with a history of medullary thyroid carcinoma or certain other conditions will need to discuss this with a prescriber before starting. For those using oral contraceptives, clinical guidance advises adding a non-oral contraceptive method for the first four weeks of treatment and for four weeks after each dose increase, because the pill's absorption may be reduced.

If you are curious about whether you might be eligible, this page answers questions about accessing Mounjaro in more detail. The practical starting point is a free consultation with a prescriber who can review the full picture with you. At nume (at our pharmacy) that review happens the same day, carried out by a named GPhC-registered Independent Prescriber, not automated software. A real clinician reads your answers and makes the clinical call. If you want to explore all available options, our treatment overview sets out what is currently licensed and dispensed. When you are ready to take the next step, you can learn more about how Mounjaro works as a weight loss treatment before checking your eligibility, which takes a few minutes and costs nothing.